Diluted EPS came in at $-0.24, beat the $-0.43 consensus by $0.19.
Trailing eight quarters through Q4 2024
Common questions about Abeona Therapeutics Inc.'s Q4 2024 earnings report.
Abeona Therapeutics Inc. (ABEO) reported Q4 2024 earnings on March 20, 2025 before market open.
Abeona Therapeutics Inc. reported diluted EPS of $-0.24 for Q4 2024.
EPS beat the consensus estimate of $-0.43 by $0.19.
You can read the 10-K periodic report (0001493152-25-010978) directly on SEC EDGAR. The filing index links above go to sec.gov.